Beginning with Goldstein and Brown's Nobel prize winning work identifying the low-density lipoprotein receptor gene (LDLR), thousands of gene mutations have been implicated as causal of the FH phenotype. The gene discussed is LDLR; the disease is familial hyperaldosteronism.